|
Pharmaceutical Product Development (PPD) is in the hunt for newfangled drugs. One of the world's largest contract research organizations (CROs), PPD provides global research and development services to pharmaceutical, biotech, and medical device companies seeking regulatory approval for their products. The company offers a broad range of services, from toxicology testing and biomarker discovery in the earliest phases of drug research, to the management of large, multi-site clinical trials, in which drug compounds are tested in human subjects. PPD is also developing some of its own compounds in partnership with other firms. Its customers have included most of the world's top 50 pharmaceutical companies.
|
| | | Contact Information | |
Address: |
929 N. Front St.
Wilmington, NC 28401
| | Phone: | 910-251-0081 | | Fax: | 910-762-5820 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1569.90 M | | Revenue Growth (1 yr): | 11.00% | | Employees (2008): | 10,500 | | Employee Growth (1 yr): | 2.90% |
|
|
Key People
| | • |
Chairman:
Fredric N. (Fred) Eshelman
| | • |
CEO and Director:
David L. Grange
| | • |
COO:
William J. (Bill) Sharbaugh
|
|
|
